サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1317644

人工臓器：世界市場

Artificial Organs: Global Markets

出版日
発行
BCC Research
ページ情報
英文 114 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
人工臓器：世界市場
出版日: 2023年07月24日
発行: BCC Research
ページ情報: 英文 114 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の人工臓器の市場規模は、2023年の144億米ドルから、予測期間中は4.2%のCAGRで推移し、2028年には177億米ドルの規模に成長すると予測されています。

製品タイプ別で見ると、人工腎臓の部門は、2023年の58億米ドルから、予測期間中は3.3%のCAGRで推移し、2028年には68億米ドルに成長すると予測されています。また、人工心臓の部門は、2023年の14億米ドルから、同期間中6.5%のCAGRで推移し、2028年には19億米ドルに成長すると予測されています。

本レポートでは、世界の人工臓器の市場を調査し、市場および技術の背景、市場影響因子および市場機会の分析、市場規模の推移・予測、各種区分・地域別の詳細分析、新興技術の動向、特許動向、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 サマリー・ハイライト

  • 市場の見通し
  • 人工臓器市場のハイライト

第3章 市場概要・定義

  • 概要
  • 人工臓器

第4章 市場動向

  • 市場促進要因
  • 人口の高齢化
  • 糖尿病患者数：国別
  • 慢性腎臓病症例数：国別
  • 新興市場における人工臓器の普及
  • 市場機会
  • 市場抑制要因

第5章 市場内訳：製品タイプ別

  • 人工心臓
  • 人工腎臓
  • 人工肺
  • 人工膵臓
  • 人工内耳

第6章 COVID-19の影響分析

  • COVID-19による医療機器および製薬業界への影響
  • 選択的手術の中止/遅延
  • COVID-19が医療機器および医薬品部門に与える影響
  • COVID-19による人工臓器市場への影響

第7章 市場内訳：地域別

  • 市場概要・ディスカッション
  • 北米
  • 米国
  • カナダ
  • メキシコ
  • ラテンアメリカ
  • ブラジル
  • アルゼンチン
  • チリ
  • 欧州
  • ドイツ
  • フランス
  • 英国
  • スペイン
  • イタリア
  • その他の欧州
  • アジア太平洋
  • 中国
  • インド
  • 日本
  • その他のアジア太平洋
  • その他の地域

第8章 競合情勢

  • 産業シナリオ
  • 企業シェア

第9章 新興技術

  • 主要技術と新興技術・主要動向と新興動向
  • 組織工学と再生医療
  • Organ-on-a-Chip (臓器チップ)
  • バイオファブリケーションと3Dバイオプリンティング
  • 生体材料と生体適合性材料
  • 免疫調節および免疫寛容戦略
  • 神経インターフェースとBMI (ブレインマシンインターフェース)
  • 遺伝子編集と遺伝子治療

第10章 M&Aと資金調達の見通し

第11章 人工臓器市場の持続可能性：ESGの観点

  • 環境要因
  • 社会的要因
  • ガバナンス要因
  • ESGパフォーマンス分析：企業別
  • 結論

第12章 特許分析

  • 特許分析：製造業者別

第13章 パイプライン分析

  • 臨床試験シナリオ

第14章 企業プロファイル

  • ABIOMED
  • ABBOTT
  • BAXTER INTERNATIONAL INC.
  • B. BRAUN SE
  • COCHLEAR LTD.
  • FRESENIUS MEDICAL CARE AG & CO. KGAA
  • F. HOFFMANN-LA ROCHE AG
  • GETINGE AB
  • INSULET CORP.
  • LIVANOVA PLC
  • MEDTRONIC
  • MED-EL MEDICAL ELECTRONICS
  • NIPRO CORP.
  • SONOVA
  • TERUMO CORP.
  • TANDEM DIABETES CARE, INC.
  • YPSOMED AG
図表

List of Tables

  • Summary Table : Global Market for Artificial Organs, by Product Type, Through 2028
  • Table 1 : Global Population, Aged 60 and Older, 2010-2050
  • Table 2 : Diabetic Cases, by Country, 2000-2045
  • Table 3 : Chronic Kidney Disease Cases, by Country, 2017-2023
  • Table 4 : Global Market for Artificial Organs, by Product Type, Through 2028
  • Table 5 : Global Market for Artificial Hearts, by Region, Through 2028
  • Table 6 : Global Market for Artificial Kidneys, by Region, Through 2028
  • Table 7 : Global Market for Artificial Lungs, by Region, Through 2028
  • Table 8 : Global Market for Artificial Pancreases, by Region, Through 2028
  • Table 9 : Global Market for Cochlear Implants, by Region, Through 2028
  • Table 10 : Global Market for Artificial Organs, by Region, Through 2028
  • Table 11 : North American Market for Artificial Organs, by Country, Through 2028
  • Table 12 : Latin American Market for Artificial Organs, by Country, Through 2028
  • Table 13 : European Market for Artificial Organs, by Country, Through 2028
  • Table 14 : Asia-Pacific Market for Artificial Organs, by Country, Through 2028
  • Table 15 : RoW Market for Artificial Organs, Through 2028
  • Table 16 : Medtronic ESG Performance
  • Table 17 : Abbott ESG Performance
  • Table 18 : Cochlear Ltd. ESG Performance
  • Table 19 : Artificial Heart Patents, by Organization, 2019-2022
  • Table 20 : Artificial Kidney Patents, by Organization, 2019-2022
  • Table 21 : Artificial Lung Patents, by Organization, 2019-2022
  • Table 22 : Artificial Pancreas, by Organization, 2019-2022
  • Table 23 : Cochlear Implants, by Organization, 2019-2022
  • Table 24 : Selected Artificial Heart Devices in Clinical Trials, 2023
  • Table 25 : Selected Artificial Kidney Devices in Clinical Trials, 2023
  • Table 26 : Selected Artificial Lung Devices in Clinical Trials, 2023
  • Table 27 : Selected Artificial Pancreas in Clinical Trials, 2023
  • Table 28 : Selected Cochlear Implants in Clinical Trials, as of 2023
  • Table 29 : Abbott: Revenue, by Segment, 2020-2022
  • Table 30 : Abbott: Revenue, by Region, 2020-2022
  • Table 31 : Baxter International Inc.: Revenue, by Segment, 2020-2022
  • Table 32 : Baxter International Inc.: Revenue, by Region, 2021 and 2022
  • Table 33 : F. Hoffmann-La Roche Ltd.: Financials, 2020-2022
  • Table 34 : F. Hoffmann-La Roche Ltd.: Revenue, by Diagnostic Segment, 2020-2022
  • Table 35 : Getinge AB: Revenue, by Segment, 2020-2022
  • Table 36 : Insulet Corp.: Revenue, by Segment, 2020-2022
  • Table 37 : LivaNova: Revenue, by Segment, 2020-2022
  • Table 38 : Nipro Corp.: Revenue, by Segment, 2020-2022
  • Table 39 : Sonova: Revenue, by Segment, 2021 and 2022
  • Table 40 : Sonova: Revenue, by Region, 2021 and 2022
  • Table 41 : Acronyms Used in This Report

List of Figures

  • Summary Figure A : Global Market for Artificial Organs, by Product Type, 2020-2028
  • Summary Figure B : Global Market Shares of Artificial Organs, by Product Type, 2022
  • Figure 1 : Global Market for Artificial Organs, by Product, 2020-2028
  • Figure 2 : Global Market Shares of Artificial Organs, by Product, 2022
  • Figure 3 : Global Market for Artificial Hearts, by Region, 2020-2028
  • Figure 4 : Global Market Shares of Artificial Hearts, by Region, 2022
  • Figure 5 : Global Market for Artificial Kidneys, by Region, 2020-2028
  • Figure 6 : Global Market Shares of Artificial Kidneys, by Region, 2022
  • Figure 7 : Global Market for Artificial Lungs, by Region, 2020-2028
  • Figure 8 : Global Market Shares of Artificial Lungs, by Region, 2022
  • Figure 9 : Global Market for Artificial Pancreases, by Region, 2020-2028
  • Figure 10 : Global Market Shares of Artificial Pancreases, by Region, 2022
  • Figure 11 : Global Market for Cochlear Implants, by Region, 2020-2028
  • Figure 12 : Global Market Shares of Cochlear Implants, by Region, 2022
  • Figure 13 : Global Market Shares of Artificial Organs, by Region, 2022
  • Figure 14 : North American Market Shares of Artificial Organs, by Country, 2022
  • Figure 15 : Latin American Market Shares of Artificial Organs, by Country, 2022
  • Figure 16 : European Market Shares of Artificial Organs, by Country, 2022
  • Figure 17 : Asia-Pacific Market Shares of Artificial Organs, by Country, 2022
  • Figure 18 : Global Market Shares of Artificial Organs, by Company, 2022
  • Figure 19 : Global Market Shares of Artificial Heart, by Company, 2022
  • Figure 20 : Global Market Shares of Artificial Kidney, by Company, 2022
  • Figure 21 : Global Market Shares of Artificial Lung, by Company, 2022
  • Figure 22 : Global Market Shares of Artificial Pancreas, by Company, 2022
  • Figure 23 : Global Market Shares of Cochlear Implants, by Company, 2022
  • Figure 24 : Emerging Trends/Technologies in the Artificial Organs Market
  • Figure 25 : Abiomed: Company Revenue, 2020-2022
  • Figure 26 : Abbott: Company Revenue, 2020-2022
  • Figure 27 : Abbott: Revenue Share, by Segment, 2022
  • Figure 28 : Abbott: Revenue Share, by Region
  • Figure 29 : Baxter International Inc.: Company Revenue, 2020-2022
  • Figure 30 : Baxter International Inc.: Revenue Share, by Segment, 2022
  • Figure 31 : B. Braun: Company Revenue, 2020-2022
  • Figure 32 : Cochlear: Implant Sales, 2020-2022
  • Figure 33 : Fresenius Medical Care: Revenue, 2020-2022
  • Figure 34 : Getinge AB: Company Revenue, 2020-2022
  • Figure 35 : Insulet Corp.: Company Revenue, 2020-2022
  • Figure 36 : LivaNova: Company Revenue, 2020-2022
  • Figure 37 : Medtronic: Company Revenue, 2020-2022
  • Figure 38 : Nipro Corp.: Company Revenue, 2020-2022
  • Figure 39 : Nipro Corp.: Revenue Share, by Segment, 2022
  • Figure 40 : Nipro Corp.: Revenue Share, by Region/Country, 2022
  • Figure 41 : Sonova: Company Revenue, 2021 and 2022
  • Figure 42 : Sonova: Revenue Share, by Segment, 2022
  • Figure 43 : Sonova: Revenue Share, by Region, 2022
  • Figure 44 : Tandem Diabetes Care: Company Revenue, 2020-2022
  • Figure 45 : Ypsomed: Company Revenue, 2020-2022
目次
Product Code: MDS091A

Highlights:

The global artificial organs market should reach $17.7 billion by 2028 from $14.4 billion in 2023 at a compound annual growth rate (CAGR) of 4.2% for the forecast period of 2023 to 2028.

Artificial kidney segment of the global artificial organs market is expected to grow from $5.8 billion in 2023 to $6.8 billion in 2028 at a CAGR of 3.3% for the forecast period of 2023 to 2028.

Artificial heart segment of the global artificial organs market is expected to grow from $1.4 billion in 2023 to $1.9 billion in 2028 at a CAGR of 6.5% for the forecast period of 2023 to 2028.

Report Scope:

This report is a comprehensive study of the global artificial organs market. It describes the artificial organs market, segmented by product type and region. Based on product type, the market is segmented into artificial hearts, artificial kidneys, artificial lungs, artificial pancreases, and cochlear implants. The market is segmented by region into North America, Latin America, Europe, Asia-Pacific, and the Rest of the World (RoW).

This report examines the factors driving growth in the artificial organ market, and it reviews major players, established companies, and new entrants.

This report, however, does not cover artificial limbs, artificial eyes, artificial intestines, artificial skin, or artificial blood vessels.

Report Includes:

  • 28 data tables and 14 additional tables
  • An overview of the global artificial organs market
  • Analyses of global market trends, with data from 2020 to 2022, estimates for 2023 and projections of compound annual growth rates (CAGRs) through 2028
  • Discussion about the benefits of using artificial organs over traditional organs in transplantation surgeries, and increase in development of new types of artificial organs as driving factors to the market
  • Identification of challenges and discussion on how to overcome from those to reach its commercialization potential
  • Insights into R&D investments, government growth-promoting policies, rules, and regulations
  • Information on recent mergers, acquisitions, collaborations, agreements, partnerships, product launches, and expansions in the market and a relevant patent analysis
  • Detailed company profiles of major players in the market, including Abbott, Getinge AB, LivaNova, Nipro Corp. and Sonova

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Methodology
  • Information Sources
  • Primary Research
  • Secondary Research
  • Geographic Breakdown

Chapter 2 Summary and Highlights

  • Market Outlook
  • Highlights of the Artificial Organs Market

Chapter 3 Market Overview and Definitions

  • Overview
  • Artificial Organs

Chapter 4 Market Trends

  • Market Drivers
  • Aging Population
  • Diabetic Cases by Countries
  • Chronic Kidney Disease Cases by Countries
  • Penetration of Artificial Organs in Emerging Markets
  • Market Opportunity
  • Market Restraints

Chapter 5 Market Breakdown by Product Type

  • Introduction
  • Artificial Heart
  • Artificial Kidney
  • Artificial Lung
  • Artificial Pancreas
  • Cochlear Implant

Chapter 6 COVID-19 Impact Analysis

  • Introduction
  • COVID-19 Impact on the Medical Devices and Pharmaceutical Industries
  • Decline/Delay in Elective Procedures
  • Impact of COVID-19 on Medical Device and Pharmaceutical Product Segments
  • COVID-19 Impact on Artificial Organs Markets

Chapter 7 Market Breakdown by Region

  • Market Overview and Discussion
  • North America
  • U.S.
  • Canada
  • Mexico
  • Latin America
  • Brazil
  • Argentina
  • Chile
  • Europe
  • Germany
  • France
  • U.K.
  • Spain
  • Italy
  • Rest of Europe
  • Asia-Pacific
  • China
  • India
  • Japan
  • Rest of Asia-Pacific
  • Rest of the World

Chapter 8 Competitive Landscape

  • Industry Scenario
  • Company Shares

Chapter 9 Emerging/Upcoming Technologies

  • Key/Emerging Technologies/Trends in the Market
  • Tissue Engineering and Regenerative Medicine
  • Organ-on-a-Chip
  • Bio-fabrication and 3D Bioprinting
  • Biomaterials and Biocompatible Materials
  • Immunomodulation and Immunotolerance Strategies
  • Neural Interfaces and Brain-Machine Interfaces
  • Gene Editing and Gene Therapy

Chapter 10 M&A and Fundings Outlook

  • M&A Analysis
  • SynCardia System's Acquisition by Versa Capital Management
  • Abiomed's Acquisition of Berlin Heart
  • LivaNova's Acquisition of TandemLife
  • Fresenius Medical Care's Acquisition of NxStage Medical
  • B. Braun's Acquisition of NxStage Medical's Bloodlines Business
  • LivaNova's Acquisition of TandemLife
  • Cantel Medical's Acquisition of hemodialysis business from Gambro
  • Eli Lilly's Acquisition of Protomer Technologies
  • Johnson & Johnson Acquisition of Abiomed Inc.

Chapter 11 Sustainability in Artificial Organs Market: An ESG Perspective

  • Introduction
  • Environmental Factors
  • Social Factors
  • Governance Factors
  • Artificial Organs Market: ESG Performance Analysis, by Company
  • Conclusion

Chapter 12 Patent Analysis

  • Patent Analysis by Manufacturer

Chapter 13 Pipeline Analysis

  • Clinical Trials Scenario

Chapter 14 Company Profiles

  • ABIOMED
  • ABBOTT
  • BAXTER INTERNATIONAL INC.
  • B. BRAUN SE
  • COCHLEAR LTD.
  • FRESENIUS MEDICAL CARE AG & CO. KGAA
  • F. HOFFMANN-LA ROCHE AG
  • GETINGE AB
  • INSULET CORP.
  • LIVANOVA PLC
  • MEDTRONIC
  • MED-EL MEDICAL ELECTRONICS
  • NIPRO CORP.
  • SONOVA
  • TERUMO CORP.
  • TANDEM DIABETES CARE, INC.
  • YPSOMED AG